Federation of Clinical Immunology Societies

Federation of Clinical Immunology Societies
💡No image available
Overview

The Federation of Clinical Immunology Societies (FOCIS) is an international umbrella organization that coordinates scientific and educational activities among national and regional societies focused on clinical immunology. It promotes collaboration across disciplines such as immunology, allergy, and related fields, and supports professional development through meetings, training initiatives, and publications.

Overview

FOCIS was established to strengthen the global clinical immunology community by providing a platform for societies and individual researchers to share knowledge and standards of care. Rather than replacing member organizations, it functions as a federation, linking groups that represent diverse patient populations, research traditions, and clinical systems.

Through its networks, FOCIS engages with issues that commonly intersect across immunology specialties, including allergic disease, primary immunodeficiencies, and transplant-related immune responses. The federation also helps create venues where clinicians and scientists can translate findings into practice, reflecting the broader role of immunology and clinical research communities.

Governance and membership

FOCIS operates as a federation composed of member societies, which typically nominate representatives and contribute to the federation’s agenda. Governance structures commonly include committees aligned with scientific, educational, and member-relations priorities, enabling continuity between international meetings and year-round activities.

Member participation supports harmonization of professional interests, including training for early-career investigators. In this role, the federation’s work complements national professional bodies and aligns with standards discussed in venues associated with medical education and clinical research.

Scientific meetings and educational programs

A central function of FOCIS is convening conferences that assemble clinicians, translational scientists, and immunologists. These meetings often highlight emerging research in areas such as allergy, autoimmunity, and immunotherapy. By supporting interdisciplinary sessions, FOCIS encourages cross-fertilization between bench science and bedside applications.

FOCIS also supports education and skills development through targeted programs, mentorship activities, and session formats designed for trainees. Such initiatives reinforce pathways for investigators transitioning from research training to independent work, an emphasis that connects with themes in translational medicine.

Collaboration and impact

By linking member societies, FOCIS helps disseminate best practices and foster collaboration across borders. International coordination is particularly relevant for rare and complex immune disorders, where patient registries, multicenter trials, and shared diagnostic frameworks can be essential. The federation’s activities therefore intersect with the broader infrastructure of rare disease research and clinical networks.

FOCIS also promotes engagement with evolving scientific concepts in immunology, including advances in understanding immune signaling, diagnostics, and patient stratification. Its role as a coordinating body supports sustained momentum in collaborative efforts that affect guidelines and clinical decision-making, often mediated through professional and scholarly channels associated with clinical guidelines.

Relationship to other immunology organizations

FOCIS functions within a wider landscape of international and regional immunology organizations. It collaborates and remains complementary to large-scale meetings and society structures that serve the global community. This ecosystem includes organizations and congresses such as World Allergy Organization and major scientific gatherings organized through established professional networks.

The federation’s member-society model also distinguishes it from purely disciplinary societies, emphasizing connective tissue between national clinical immunology bodies. In practice, this approach supports continuity between local expertise and international scientific priorities, while reinforcing the shared mission of improving outcomes for patients with immune-mediated conditions.